Home > Legislation > 116th Congress > H.R.2038

H.R.2038 - State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019116th Congress (2019-2020)

Bill

Hide Overview
Sponsor: Rep. Meadows, Mark [R-NC-11] (Introduced 04/02/2019)
Committees: House - Judiciary
Latest Action: House - 05/15/2019 Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.  (All Actions)

Tracker:

This bill has the status Introduced

Here are the steps for Status of Legislation:

  1. Introduced

More on This Bill

  • Constitutional Authority Statement
  • CBO Cost Estimates [0]

Subject — Policy Area:

Summary: H.R.2038 — 116th Congress (2019-2020)All Information (Except Text)

There is one summary for H.R.2038. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (04/02/2019)

State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019

This bill authorizes health insurance issuers to jointly negotiate the prices for prescription drugs with the manufacturers of such drugs.